CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $7.02 ($14,033)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $7.24 ($14,470)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.95 ($13,900)
- 4 Open-market buy Director bought 1,000 shares at $6.80 ($6,800)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.48 ($12,950)
- 4 Open-market buy Director bought 4,000 shares at $6.57 ($26,280)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.27 ($12,530)
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 60 of 76 · 1,519 filings